NORTH ANDOVER, Mass.--(BUSINESS WIRE)--May 9, 2006--Aurora Imaging Technology, Inc. (Aurora) announced today the sale of $10 million of Series C Preferred Stock to two equity funds managed by the Pharos Capital Group (Pharos Capital Partners II and Pharos Capital Partners II-A). Aurora will use the new capital to expand selling and marketing activities both nationally and internationally in commercialization of the Aurora 1.5T Dedicated Breast MRI System with Bilateral UltraRODEO®. Aurora manufactures the only breast MRI system designed specifically and exclusively for breast imaging optimized to detect and diagnose breast cancer.
